Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 18INDUSTRY 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1

Conditions

Neoplasms 2Fatigue 2Prostatic Neoplasms 1Multiple Myeloma 1Melanoma 1Breast Neoplasms 1

Interventions

Modafinil 2reparixin 1clazakizumab 1Walking 1Sodium Chloride 1Saline Solution 1Methylphenidate 1Lenalidomide 1EOM613 1Darbepoetin alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Fatigue × Modafinil × Clear all
NCT00825227 2017-11-17

Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 2 Terminated
10 enrolled 7 charts

Fatigue, Neoplasms

NCT01160380 2014-11-06

A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma

Oncotherapeutics

Phase 3 Completed
50 enrolled 14 charts
Plasma cell

Fatigue, Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡